Both formats supply the same underlying compound. The difference is what you're paying for on top of it, and how easily you can verify what's actually inside. Here's the real comparison, using our own catalogue pricing.
A pre-filled pen and a lyophilised vial can supply the exact same total amount of compound. The pen simply costs more to produce — an injector mechanism, a sealed cartridge, and a pre-fill manufacturing process all add cost that has nothing to do with the peptide itself.
You don't need to take our word for it. Here's the same compound, same total content, both currently in our own catalogue:
| Format | Content | Price | Per mg |
|---|---|---|---|
| Retatrutide Vial | 40mg lyophilised | £80.00 | £2.00/mg |
| Retatrutide Pre-Filled Pen | 40mg | £145.00 | £3.63/mg |
A vial arrives as a visible lyophilised (freeze-dried) powder. You can see it, weigh the vial, reconstitute it yourself, and independently send a sample for third-party HPLC testing if you want to confirm purity and concentration before use.
A pre-filled pen arrives as a liquid, already mixed, sealed inside a proprietary cartridge. There's no powder to inspect, no reconstitution step where you'd notice if something looked wrong, and testing the contents means destructively opening a device that was designed to stay sealed. You're trusting the manufacturer's fill process end-to-end, with no independent checkpoint of your own.
Reconstituted peptides have a limited safe-use window — commonly kept to around 28-30 days once mixed and refrigerated (see our reconstitution guide for the full storage breakdown). Managing that window properly depends on knowing exactly when the clock started.
Reconstitute a vial yourself and day zero is the day you mix it — you know the exact age of your solution at every point, and can plan your research schedule around it with confidence.
A pre-filled pen is mixed by the manufacturer as a liquid before it's ever shipped to you. It's already been sitting reconstituted through packaging, warehousing, and shipping time before it reaches your door — and there's no way to know exactly how long that was. You could be starting your 30-day window with a meaningful chunk of it already gone.
With a vial, you choose the reconstitution volume, which sets your own concentration and lets you titrate doses precisely across different experimental arms from a single vial. A pre-filled pen delivers a fixed formulation — convenient if a single consistent dose is exactly what you need, but far less adaptable if your protocol calls for a different concentration or split dosing from the same stock.
Pens aren't without a genuine advantage: no bacteriostatic water, no syringes, no reconstitution step — just a ready-to-use device. If dosing consistency with zero setup matters more to you than cost per mg or independent verification, that's a legitimate trade-off. It's exactly why we still stock the Re:Age pre-filled pen alongside our vial range, rather than not offering the format at all.
The vast majority of Nova Biolabs' catalogue is lyophilised vials, with the pre-filled pen offered as the exception rather than the default. That's a deliberate choice based on exactly the reasoning above: for most researchers, the lower cost per mg and the ability to independently verify a visible powder outweigh the convenience of a sealed, pre-mixed device.